|
SRGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.416090E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.041700E-03 |
| Normal-vs-Stage2 |
1.105190E-01 |
| Normal-vs-Stage3 |
3.170400E-04 |
| Normal-vs-Stage4 |
3.641300E-04 |
| Stage1-vs-Stage2 |
5.334600E-01 |
| Stage1-vs-Stage3 |
2.637000E-01 |
| Stage1-vs-Stage4 |
1.787820E-01 |
| Stage2-vs-Stage3 |
2.236600E-01 |
| Stage2-vs-Stage4 |
1.626010E-01 |
| Stage3-vs-Stage4 |
7.409200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.699600E-03 |
| Normal-vs-AfricanAmerican |
1.036330E-02 |
| Normal-vs-Asian |
5.276600E-03 |
| Caucasian-vs-AfricanAmerican |
5.482200E-01 |
| Caucasian-vs-Asian |
7.948000E-01 |
| AfricanAmerican-vs-Asian |
6.316800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.167200E-04 |
| Normal-vs-Female |
3.338700E-03 |
| Male-vs-Female |
5.256600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.577800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.279400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.864410E-03 |
| Normal-vs-Age(81-100Yrs) |
2.261700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.394600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.681400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.573200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.805000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.951600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.849000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.338100E-02 |
| Classical-VS-Follicular |
5.620000E-02 |
| Classical-VS-Other |
4.400600E-01 |
| Classical-VS-Normal |
1.502470E-02 |
| Tall-VS-Follicular |
7.654000E-01 |
| Tall-VS-Other |
9.718400E-01 |
| Tall-VS-Normal |
1.136100E-03 |
| Follicular-VS-Other |
9.207000E-01 |
| Follicular-VS-Normal |
1.559920E-03 |
| Other-VS-Normal |
7.773800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.323000E-03 |
| Normal-vs-N1 |
1.720150E-03 |
| N0-vs-N1 |
4.068000E-01 |
|
|
